It has been reported that the over-expression of REIC/DKK3 in cancer cells can induce apoptosis, and there are clinical trials of REIC/DKK3 gene therapy for prostate cancer [42], liver cancer [43], and endometrial cancer [44]. The gene discussed is DKK3; the disease is endometrial cancer.